Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use

Using an Electronic Health Record-based Intervention and Broad Education Reach Strategies to Improve Quality of Care for GERD and Gastroprotection for Patients on NSAIDs: a Randomized Controlled Trial

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00691171

Enrollment

5234

Registered

2008-06-05

Start date

2007-01-31

Completion date

2008-06-30

Last updated

2015-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD

Keywords

gastroesophageal reflux disease, GERD, nonsteroidal anti-inflammatory drugs, peptic ulcer, Diagnosed GERD, Atypical GERD symptoms, chronic NSAID therapy, Risk for ulcer

Brief summary

The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Eligibility as determined by criteria for participation in studies as part of the MQIC * Agreement of participating clinical practices to undergo training in the electronic health record (EHR) intervention designed for this study

Exclusion criteria

* Based on voluntary participation by MQIC practices, so practices were excluded if they decided to opt out

Design outcomes

Primary

Measure	Time frame
Diagnoses of GERD	After 12 months of intervention
Prescriptions for gastroprotective medicines in at-risk, chronic NSAID users	After 12 months of intervention

Secondary

Measure	Time frame
Prescriptions for GERD medications	After 12 months of intervention
Change in GERD symptoms score	After 12 months of intervention
NSAID-related GI complications	After 12 months of intervention

Outcome results